Patent ID: 9532945
Date: 2017-01-03
CPC Classifications: A61K,A61P

Claim:
1. A method of protecting the gastrointestinal tract of a patient from developing side effects associated with antiplatelet therapy with clopidogrel, wherein said patient does not have gastrointestinal bleeding or a gastrointestinal ulcer comprising: orally administering to said patient a single unit oral dosage form comprising: wherein the omeprazole, but not the clopidogrel, is within an enteric coated formulation comprising: (i) a core material comprising an inert nucleus coated with a layer comprising the omeprazole, an alkaline material, and a binding agent; and (ii) an outer enteric coating comprising an enteric material, a plasticizer, and a surfactant, wherein (i) and (ii) are separated by an intermediate barrier comprising a binding agent, and wherein the single unit oral dosage form excludes a non-aspirin nonsteroidal anti-inflammatory drug (NSAID).